These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25545541)

  • 1. Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series.
    Nielsen S; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N
    Drug Alcohol Rev; 2015 May; 34(3):304-11. PubMed ID: 25545541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
    Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
    Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.
    Sankey C; Setnik B; Harsanyi Z; Michalko K; Yang Z; Geoffroy P
    J Opioid Manag; 2016; 12(2):149-59. PubMed ID: 27194200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids.
    Lam T; Hayman J; Berecki-Gisolf J; Sanfilippo P; Lubman DI; Nielsen S
    Addiction; 2022 Mar; 117(3):623-636. PubMed ID: 34338377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
    Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
    Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
    Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
    Verthein U; Beck T; Haasen C; Reimer J
    Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
    Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
    J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
    Ytterberg SR; Mahowald ML; Woods SR
    Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fatal poisonings by prescription opioids.
    Häkkinen M; Launiainen T; Vuori E; Ojanperä I
    Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011.
    Nielsen S; Roxburgh A; Bruno R; Lintzeris N; Jefferson A; Degenhardt L
    Drug Alcohol Depend; 2015 Apr; 149():212-9. PubMed ID: 25707708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
    Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
    Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.
    Nielsen S; Cameron J; Lee N
    J Opioid Manag; 2011; 7(5):363-70. PubMed ID: 22165035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.